Bad blood: (Record no. 6790)

MARC details
000 -LEADER
fixed length control field 02243nam a22001817a 4500
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20240513160714.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 240513b |||||||| |||| 00| 0 eng d
020 ## - INTERNATIONAL STANDARD BOOK NUMBER
International Standard Book Number 9781509868070
082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER
Classification number 823.92
Item number CAR
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Carreyrou, John
245 ## - TITLE STATEMENT
Title Bad blood:
Remainder of title secrets and lies in a silicon valley startup
260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT)
Place of publication, distribution, etc. New York
Name of publisher, distributor, etc. London
Date of publication, distribution, etc. 2018
300 ## - PHYSICAL DESCRIPTION
Extent x, 339 p.
365 ## - TRADE PRICE
Price type code GBP
Price amount 14.99
520 ## - SUMMARY, ETC.
Summary, etc. Now with a new afterword covering the months-long landmark trials of Theranos founders Elizabeth Holmes and Sunny Balwani.<br/><br/>‘I couldn’t put down this thriller . . . a book so compelling that I couldn't turn away’ – Bill Gates<br/><br/>‘A story so incredible you'd think it was fiction' – James Patterson<br/><br/>Winner of the Financial Times/McKinsey Business Book of the Year Award.<br/><br/>The shocking true story of the breathtaking rise and collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, written by the prize-winning journalist who first broke the story and pursued it to the end.<br/><br/>Seen as the female Steve Jobs, Theranos founder and CEO Elizabeth Holmes was a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by wealthy investors, Theranos sold shares that valued the company at more than $9 billion.<br/><br/>There was just one problem: the technology didn’t work . . .<br/><br/>Despite threats of legal action, brave whistleblowers started to talk. They revealed a culture of intimidation and secrecy, technology that repeatedly failed, results sent to real patients that were incorrect but upon which life-changing medical decisions were being made, with devastating consequences.<br/><br/>The riveting story behind The Dropout, in Bad Blood, John Carreyrou investigates the biggest corporate fraud since Enron, a tale of ambition and scandal set amid the bold promises of Silicon Valley.<br/><br/>'A tale of corporate fraud and legal browbeating that reads like a crime thriller' - The 10 Best Nonfiction Books, TIME<br/><br/>(https://www.panmacmillan.com/authors/john-carreyrou/bad-blood/9781035006779)
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name as entry element Mystery fiction
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme Dewey Decimal Classification
Koha item type Book
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Collection code Home library Current library Shelving location Date acquired Source of acquisition Total Checkouts Full call number Accession Number Date last seen Copy number Cost, replacement price Price effective from Koha item type
    Dewey Decimal Classification     Non-fiction Indian Institute of Management LRC Indian Institute of Management LRC General Stacks 05/13/2024 Gratis Book   823.92 CAR G00061 05/13/2024 1 1568.82 05/13/2024 Book
    Dewey Decimal Classification     Non-fiction Indian Institute of Management LRC Indian Institute of Management LRC General Stacks 07/09/2024 Gratis Book   823.92 CAR G00276 07/09/2024 1 1601.21 07/09/2024 Book

©2019-2020 Learning Resource Centre, Indian Institute of Management Bodhgaya

Powered by Koha